Barclays
VSEE

Barclays’s VSee Health VSEE Stock Holding History

Barclays’s Portfolio VSEE Stock Details VSEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-424,225
Closed -$4.3M – 5402
2022
Q3 		$4.3M Hold
424,225
– – ﹤0.01% 1256
2022
Q2 		$4.25M Buy
424,225
+337,173
+387% +$3.38M ﹤0.01% 1424
2022
Q1 		$871K Buy
+87,052
New +$865K ﹤0.01% 2518

Other funds holding VSEE

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Barclays's VSEE Position: Q4 2022 in Review

Barclays sold out of VSee Health (VSEE) in Q4 2022, closing a stake of 424,225 shares — an estimated $4.3M sold.

Barclays first reported a position in VSEE in Q1 2022 and held it in 3 quarters. The position peaked at $4.3M in Q3 2022. 9 funds tracked by Wall St. Rank hold VSEE as of Q4 2022.

  • Barclays reported no remaining VSee Health position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 424,225 VSee Health shares in Q4 2022, an estimated $4.3M.
  • Barclays first reported a position in VSee Health in Q1 2022 and held it in 3 quarters.
  • Barclays's VSee Health position peaked at $4.3M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held VSee Health as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.